Spire Healthcare Group (LON:SPI) Trading 14.1% Higher - Time to Buy?

Key Points

• Spire Healthcare Group's shares rose by 14.1%, reaching a high of GBX 256.50 ($3.48) during trading, significantly above its previous close of GBX 216.50 ($2.93).
• Analyst ratings show a consensus of "Buy" with a price target averaging GBX 294.33, although JPMorgan Chase & Co. recently adjusted their target down to GBX 303.
• The company reported earnings of GBX 4.10 per share for the latest quarter, with predictions of approximately 15.66 earnings per share for the current fiscal year.

Shares of Spire Healthcare Group plc (LON:SPI - Get Free Report) shot up 14.1% during mid-day trading on Friday . The company traded as high as GBX 256.50 ($3.46) and last traded at GBX 247 ($3.33). 9,747,062 shares traded hands during trading, an increase of 563% from the average session volume of 1,469,073 shares. The stock had previously closed at GBX 216.50 ($2.92).

Analyst Ratings Changes

Several equities analysts have weighed in on the company. Berenberg Bank reissued a "buy" rating and set a GBX 280 price target on shares of Spire Healthcare Group in a research report on Thursday, July 31st. JPMorgan Chase & Co. cut their price objective on shares of Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating on the stock in a report on Tuesday, August 5th. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus price target of GBX 294.33.

Spire Healthcare Group Trading Up 14.1%

The company has a current ratio of 0.70, a quick ratio of 0.74 and a debt-to-equity ratio of 62.25. The firm has a market cap of £993.86 million, a PE ratio of 5,369.57, a P/E/G ratio of 1.06 and a beta of 0.96. The company's 50-day moving average is GBX 218.75 and its 200 day moving average is GBX 203.41.

Spire Healthcare Group (LON:SPI - Get Free Report) last released its earnings results on Thursday, July 31st. The company reported GBX 4.10 earnings per share (EPS) for the quarter. Spire Healthcare Group had a net margin of 1.96% and a return on equity of 3.82%. As a group, sell-side analysts predict that Spire Healthcare Group plc will post 15.6634747 EPS for the current year.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.